Yesterday, 10x Genomics, Inc., a pioneer in the realms of single-cell and spatial biology, proudly announced the release of its Visium HD Spatial Gene Expression product. This groundbreaking tool, designed for the detailed exploration of the whole transcriptome from FFPE tissue sections at a single-cell resolution, sets a new benchmark in the field. Yesterday’s Highlights: […]
Category: Learning
Crash Course on mRNA Therapeutics and the CDMO Space
Understanding mRNA Therapy: A Primer mRNA (messenger RNA) therapy is a revolutionary approach in biotechnology that utilizes synthetic mRNA to instruct cells to produce therapeutic proteins. This strategy can be applied to a wide array of diseases, including infectious diseases, cancer, and genetic disorders. Unlike traditional therapies that often introduce proteins or small molecules to […]
Epigenetic Revolution: Redefining Medicine’s Frontier
The global epigenetics market is set to soar, projected to reach $6.35 billion by 2032 from $2.14 billion in 2023, according to a recent Precedence Research report. Driving this surge are pioneering ventures like Moonwalk Biosciences, led by CRISPR luminary Feng Zhang, and Novo Nordisk’s partnership with Omega Therapeutics, signaling a seismic shift in the […]
2024 CDMO Sector Evolution: Key Trends
In 2024, the CDMO sector is navigating through transformative changes driven by customer needs, agility, digitalization, and environmental sustainability. These trends are shaping the future of pharmaceutical manufacturing with a focus on excellence. 1. Customer-Centric Initiatives:– Operations and designs are finely tuned to the specific requirements of biopharma clients, ensuring services are aligned with customer […]